Starpharma (ASX: SPL)

Last close As at 18/12/2025

AUD0.32

−0.02 (−4.48%)

Market capitalisation

AUD141m

Starpharma is an Australian biotechnology company with two decades of experience in advancing dendrimer technologies from the lab to the patient.

Latest Insights

Healthcare | edison tv

Starpharma – executive interview

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Cheryl Maley

    CEO & Managing Director

  • Justin Cahill

    CFO & Company Secretary